ELTX- Elicio Therapeutics, Inc.

Name: Elicio Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Elicio Therapeutics, Inc. (ELTX) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. ELTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Chudnovsky Yekaterina	103.2K	$1.03M	-
Other	Haqq Christopher	57.4K	$574.4K	-
Dir	Venkatesan Jay	7.9K	$79.1K	-
Dir	Nissenson Allen	7.9K	$79.1K	-
Dir	Ruffolo Robert R	7.9K	$79.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 22, 2023	Chudnovsky Yekaterina	Director, 10% Owner	Buy	1,213,000	$5.81	$7,047,530.00	+172.6%	+2.3%	-24.3%
May 25, 2022	Venkatesan Jay	See Remarks	Buy	11,313	$1.25	$14,102.79	+0.6%	-19.8%	-32.5%
May 24, 2022	Venkatesan Jay	See Remarks	Buy	82,200	$1.23	$101,428.00	+2.5%	-17.9%	-33.3%
May 20, 2022	Nissenson Allen	Director	Buy	9,383	$1.16	$10,925.02	+127.7%	-20.3%	-38.3%
Dec 28, 2021	Venkatesan Jay	See Remarks	Buy	277,244	$2.63	$730,373.17	+9.9%	-17.0%	-67.6%
Dec 20, 2021	Neylan John F.95	See Remarks	Sell	358	$2.62	$938.00	-1.0%	-17.6%	-68.1%
Dec 20, 2021	Venkatesan Jay	See Remarks	Buy	3,527	$2.54	$8,975.86	+0.3%	-17.6%	-68.1%
Dec 17, 2021	Venkatesan Jay	See Remarks	Buy	41,625	$2.55	$105,951.18	+1.6%	-12.5%	-66.7%
Dec 15, 2021	Curhan Gregory S	See Remarks	Buy	4,000	$2.37	$9,480.00	New	-29.3%	-66.3%
Dec 15, 2021	Venkatesan Jay	See Remarks	Buy	77,604	$2.41	$186,955.80	+6.3%	-29.3%	-66.3%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC